SCYX: SCYNEXIS, Inc. Consensus Target

SCYNEXIS, Inc. (SCYX) develops unique triterpenoid antifungals, holding exclusive patent rights amid growing pathogen resistance. The stock price action, reaching 32.63, confirms management's success in bringing innovations to market and securing global partners. Supply stability is ensured through optimized routing and inventory levels, guaranteeing the seamless distribution of medications.

SCYX Scynexis Consensus Target (07/04/2022 - 11/11/2026)

Analytical breakdowns for SCYNEXIS, Inc. (SCYX)

- price and consensus price forecast:

Market Chart scynexis.com|SCYX - Analyst Consensus Forecast

- market capitalization information:

Market Valuation Scynexis|SCYX - Real Price to Acquire Entire Company

- book value of equity indicators:

Net Asset Value per Share SCYNEXIS|SCYX - Company Net Assets|Capitalization to Book Value Ratio scynexis.com|SCYX - Aggregate Company Assets

- business debt structure and liquidity details:

- earnings and multiples data:

SCYX - Net Profit|Projected Future Earnings SCYNEXIS, Inc.|SCYX - Price to Earnings Ratio|Future Price to Earnings Multiple scynexis.com|SCYX - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Scynexis|SCYX - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months SCYNEXIS|SCYX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share trend for the last twelve months scynexis.com|SCYX - Earnings growth in current year|Expected net earnings per share growth next year SCYNEXIS, Inc.

General company analysis:SCYX SCYNEXIS Inc

The success of SCYNEXIS, Inc. (SCYX) depends on the ability of its partners to scale sales of the patented Brexafemme under stringent FDA regulations. The consensus forecast reflects the average expectation of investment houses regarding the asset's fair value, capturing a real-time reassessment of the business's fundamental prospects. Analyzing the history of consensus price target changes allows investors to recognize a trend reversal in a timely manner and identify an undervalued asset before a mass influx of capital.

Competitors of SCYNEXIS, Inc.